Blood thinner pellets tested in kids with clots

NCT ID NCT05966740

Terminated Disease control Sponsor: Boehringer Ingelheim Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at the safety and effectiveness of Pradaxa oral pellets in children aged 3 months to 12 years who had blood clots (venous thromboembolism). The goal was to see how often bleeding or new clots occurred in real-world use. Only 5 children were enrolled before the study was terminated, so the findings are very limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Pradaxa (dabigatran etexilate) oral pellets
What this could lead to: If successful, this study could provide real-world evidence that Pradaxa pellets are safe and effective for treating blood clots in young children.
What could go wrong: The study was terminated early with only 5 participants, so results are very limited. As an observational study, it cannot prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

venous thromboembolism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VENOUS THROMBOEMBOLISM

Contacts and locations

Locations

Cincinnati Children's Hospital

Cincinnati, Ohio, 45229, United States
Dayton Children's Hospital

Dayton, Ohio, 45404, United States
Dell Children's Ascension

Austin, Texas, 78723, United States
Indiana Hemophilia & Thrombrosis Center

Indianapolis, Indiana, 46260, United States
Johns Hopkins All Children's Hospital

St. Petersburg, Florida, 33701, United States
MUSC (Medical university of South Carolina)

Charleston, South Carolina, 29425, United States
Rady Children's Hospital

San Diego, California, 92123, United States
University of California, San Diego

La Jolla, California, 92093, United States
Vanderbilt University

Nashville, Tennessee, 37232, United States
Yale University School of Medicine

New Haven, Connecticut, 06519, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.